Bedford, MA – According to filings with the U.S. Securities and Exchange Commission, Rejoni is raising $25,000,000.00 in new funding. Sources indicate as part of senior management President, Amarpreet Sawhney played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Rejoni

At Rejoni, our team is working on developing solutions that minimize both acute and chronic risks associated with gynecologic procedures by providing womens health-centered technologies that help women to achieve the life they want both now and in the future. Working closely with leading physicians, Rejoni Inc. is conducting a clinical trial to learn if a soft gel-like material, called Juveena™ Hydrogel may prevent intrauterine adhesions after uterine surgery.

To learn more about Rejoni, visit http://rejoni.com/

Contact:
Amarpreet Sawhney, President
617-510-3859
https://www.linkedin.com/in/amar-sawhney-a4b143/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved